Abstract:Current risk stratification for stroke is still based upon percentage of carotid stenosis, despite this measure providing minimal patient-specific information on the actual risk of stroke for both symptomatic individuals without significant carotid artery stenosis as well as asymptomatic carotid stenosis patients. A continuously growing body of literature suggests that the identification and quantification of certain carotid plaque characteristics, including lipid-rich necrotic core (LRNC), thin/ruptured fibrous cap (FC), and intraplaque hemorrhage (IPH), provide a superior means of predicting future stroke. These characteristics are identifiable via magnetic resonance imaging (MRI), with most features detectable using commercially available coils and sequences utilized in routine clinical practice in as little as 4 minutes. The presence of LRNC, a thin/ruptured FC, and IPH is associated with increased risk of future stroke or TIA. Plaques with greater than 40% LRNC with a thin overlying FC are prone to rupture. LRNC is T2 hypointense and lacks enhancement on contrast enhanced T1 weighted images. Increasing LRNC size is associated with the development of new ulceration, FC rupture, increasing plaque burden, as well as fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome (ACS), and symptom-driven revascularization, allowing for MR biomarkers of carotid plaque vulnerability to be utilized for systemic athero-thrombotic risk and not just stroke/TIA. LRNC typically shrinks with appropriate statin therapy, with PCSK9 inhibitors possibly playing a role in patients with inadequate response. Carotid plaques with IPH represent a more advanced stage of atherosclerotic disease. IPH is detectable with field strengths of both 3.0 T and 1.5 T and will demonstrate high signal on all T1 weighted imaging sequences. The presence of IPH increases the risk of future stroke in both symptomatic and asymptomatic patients, with multivariate analysis identifying IPH as a predictor of stroke, independent of percent stenosis, with no statistical difference in men vs. women, demonstrating that simple carotid stenosis measurements and traditional risk factor analysis may be inadequate in identifying patients at the highest risk for adverse cerebrovascular events. In the evaluation for recurrent stroke in recently symptomatic patients with >50% carotid stenosis, the estimated annual stroke risk is 23.2% in IPH+ patients and only 0.6% in IPH- patients, calling into question the current risk-benefit assessment for CEA. Additionally, a recent meta-analysis suggests that IPH+ plaque in patients with symptomatic <50% stenosis may be the etiology of embolic strokes previously labeled as "embolic stroke of undetermined source" (ESUS). There are no prospective drug trials testing the ability of any lipid-lowering therapies to decrease IPH and/or total plaque volume (TPV). Given the continuously increasing evidence of IPH as a significant predictor of carotid plaque progression and future adverse vascular events, trials aimed at targeted therapy for IPH represents a significant need.

Imaging of intraplaque haemorrhage

Abstract TP47: Intracranial Intraplaque Hemorrhage in Acute Stroke: Interim Results of the Stroke Imaging Package Study

High Occurrence Rate Of Parent Intracranial Artery Plaque N Patients With Acute Penetrating Artery Territory Infarcts: Interim Results Of The Stroke Imaging Package Study

Abstract 10227: High-Sensitive Magnetic Particle Imaging of Intraplaque Hemorrhage for Identification of Unstable Atherosclerotic Plaques

Intravascular Photoacoustic and Autofluorescence Imaging for Detecting Intraplaque Hemorrhage: A Feasibility Study

What does the future hold for novel intravascular imaging devices: a focus on morphological and physiological assessment of plaque

The state-of-art high-resolution MRI in carotid intraplaque hemorrhage

Carotid Plaque Imaging and the Risk of Atherosclerotic Cardiovascular Disease

Quantifying effect of intraplaque hemorrhage on critical plaque wall stress in human atherosclerotic plaques using three-dimensional fluid-structure interaction models.

Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology

Intraplaque hemorrhage is associated with higher structural stresses in human atherosclerotic plaques: an in vivo MRI-based 3d fluid-structure interaction study

MR imaging of vulnerable carotid plaque

Intravascular molecular imaging: translating pathophysiology of atherosclerosis into human disease conditions

Reliable in vivo intravascular imaging plaque characterization: A challenge unmet

A Multimodality Image-Based Fluid-Structure Interaction Modeling Approach for Prediction of Coronary Plaque Progression Using IVUS and Optical Coherence Tomography Data with Follow-Up

Adventitial Perfusion and Intraplaque Hemorrhage

Magnetic Resonance Imaging Detection of Intraplaque Hemorrhage

Evaluation of Plaque Vulnerability via Combination of Hemodynamic Analysis and Simultaneous Non-Contrast Angiography and Intraplaque Hemorrhage (SNAP) Sequence for Carotid Intraplaque Hemorrhage

Imaging Biomarkers of Vulnerable Carotid Plaques for Stroke Risk Prediction and Their Potential Clinical Implications.

Intravascular Molecular Imaging: Near-Infrared Fluorescence as a New Frontier

SVD-based filtering to detect intraplaque hemorrhage using single wavelength photoacoustic imaging